The Analysis of Association Between the Disability and Multiple Autoantibodies in Neuromyelitis Optica Spectrum Disorder (NMOSD) (P6.413)
Hye Lim Lee(Korea University Medical Center), Byoung Joon Kim(Samsung Medical Center), Eun Bin Cho(Changwon National University), Ha Young Shin(Yonsei University), Seol‐Hee Baek(Korea University Medical Center), Jin Myoung Seok(Samsung Medical Center), Byung‐Jo Kim(Korea University), Sa‐Yoon Kang(Jeju National University), So‐Young Huh(Kosin University), Jong Kuk Kim(Dong-A University), Jeeyoung Oh(Université Paris-Sud), Byeol‐A Yoon(Kyungpook National University Hospital), Young‐Min Lim(Ulsan College), Kwang‐Kuk Kim(Ulsan College), Hung Youl Seok(Keimyung University), Sang Soo Lee(Chungbuk National University Hospital), Jung Bin Kim(National Cancer Center), Ju‐Hong Min(Samsung (South Korea)), Oh-Hyun Kwon(Eulji University)
Cited by 0
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
A New Subtype Classification of Ischemic Stroke Based on Treatment and Etiologic Mechanism
|European Neurology|2006|121
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders
|Multiple Sclerosis Journal|2013|84
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea
|Multiple Sclerosis Journal|2017|82